This is a preview of subscription content, log in via an institution to check access.
Notes
National Institute for Health and Care Excellence
2014 British pounds
peginterferon α-2a with ribavirin
Reference
Faria R, et al. Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals. Alimentary Pharmacology and Therapeutics : 25 Aug 2016. Available from: URL: http://doi.org/10.1111/apt.13775
Rights and permissions
About this article
Cite this article
Sequential DDAs cost effective in HCV patients with fibrosis. PharmacoEcon Outcomes News 761, 30 (2016). https://doi.org/10.1007/s40274-016-3370-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3370-0